Completed PHASE3 INTERVENTIONAL 1-arm NCT00509405

Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural

Effect of Neutralization of Endogenous Acid Production on Bone Mineral Density and Microarchitectural Composition of Bone in Humans

Sponsor: Kantonsspital Baselland Bruderholz

Conditions Healthy

Interventions potassium citrate

Updated 5 times since 2017 Last updated: Apr 23, 2012 Started: Jul 31, 2007 Primary completion: May 31, 2010 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00509405, this PHASE3 trial focuses on Healthy and remains completed. Sponsored by Kantonsspital Baselland Bruderholz, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kantonsspital Baselland Bruderholz

Data source: Kantonsspital Baselland Bruderholz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bruderholz/Basel, Switzerland